title: Towards a targeted, risk-based, antifungal strategy in neutropenic patients.
authors.affiliation: Department of Haematology, Royal Free and University College Medical School, Royal Free Campus and Hospital, London, UK. prentice@rfhsm.ac.uk
authors.forename: H G
authors.initials: HG
authors.lastname: Prentice
authors.forename: C C
authors.initials: CC
authors.lastname: Kibbler
authors.forename: A G
authors.initials: AG
authors.lastname: Prentice
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D016470:Bacteremia / Q000150:complications; D016026:Bone Marrow Transplantation; D005938:Glucocorticoids / Q000009:adverse effects; D006086:Graft vs Host Disease / Q000150:complications; D006801:Humans; D009181:Mycoses / Q000209:etiology / Q000517:prevention & control*; D009503:Neutropenia / Q000209:etiology*; D009894:Opportunistic Infections / Q000517:prevention & control; D018579:Patient Selection; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D005938:Glucocorticoids